Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
Employees: 11-50
Total raised: $19.5M
Investors 2
| Date | Name | Website |
| 25.03.2022 | LionBird | lionbird.c... |
| 26.02.2022 | NFX | nfx.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2023 | Seed | $19.5M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 12.10.2023 | Mana.bio Raises $19.5M in Seed Financing | Mana.bio, a Tel Aviv, Israel-based biotechnology company accelerating programmable drug delivery, ra... | finsmes.co... |
| 12.10.2023 | Israeli biotech startup Mana.bio launches AI-fueled programm... | Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solutio... | techcrunch... |
| 14.06.2022 | От BioTech к TechBio: как меняется сфера биотехнологий... | Биология — одна из самых развитых технологий на Земле. Представьте сотовый телефон, который может ра... | rb.ru/stor... |
| - | Mana.bio | “Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based... | fastfounde... |